Sign In

Jose Engelmayer

Biopharmaceutical Professional

Professional Background

Jose Engelmayer is an accomplished biopharmaceutical professional with a strong focus on innovative strategies that span across drug development, clinical trial management, and product commercialization. With a wealth of experience gained from his diverse career in the biopharmaceutical sector, he is recognized for his adeptness at fostering and nurturing crucial relationships with industry leaders, key opinion leaders (KOLs), and healthcare professionals (HCPs). Jose's career trajectory reveals a formidable depth of expertise in business development, market analysis, and FDA submissions, making him a vital asset in any pharmaceutical or biotech organization.

Education and Achievements

Jose's educational background is impressive. He pursued his M.B.A. at Rice University, specifically at the Jesse H. Jones Graduate School of Management, where he honed his business acumen and administrative skills that are essential in the fast-paced world of biopharmaceuticals. Additionally, he holds a Ph.D. in Biomedical Sciences with a focus on Immunology and Virology from the prestigious Rockefeller University. This advanced academic training provides him with a profound understanding of the biological principles that underlie drug development and therapeutic interventions.

Jose's career is marked by several notable achievements. He played a pivotal role in identifying and developing an indication for an immuno-oncology drug, which significantly increased the valuation of a biotech company by an impressive $60 million. His strategic initiatives not only helped secure an additional $2.45 million in revenue from NIH grants but also resulted in comprehensive market protection through the securing of eight patents. These accomplishments highlight his ability to contribute meaningfully to business development and to drive result-oriented strategies in a highly competitive market.

Furthermore, Jose's expertise in identifying contract research organizations (CROs) allowed him to efficiently lead pre-clinical and clinical development studies for various biotechnology companies. His strategic oversight has been instrumental in mitigating costs and delays, thereby facilitating the timely advancement of innovative drugs and therapies toward market approval.

Areas of Expertise and Skills

Jose Engelmayer’s skill set is broad and highly specialized, incorporating various aspects essential for success in the biopharmaceutical industry. His areas of expertise include Gene Therapy, Oncology, Immunology, NASH (Non-Alcoholic Steatohepatitis), Neurology, Dermatology, and Cardiovascular Disease, positioning him as a versatile and knowledgeable professional capable of navigating across multiple therapeutic domains.

His competencies also encompass drug development strategies, building and managing relationships with KOLs, undertaking clinical to commercial strategic planning, conducting FDA submissions, and efficiently managing CRO operations. Jose's market analysis acumen, combined with his ability to forecast trends and manage budgets, equips him to devise effective start-up strategies and economic plans that align with the goals of attracting investment and advancement.

Bosiding a diverse vocational history, he served as a Consultant for multiple BioPharma, Advisory, and Investment Management Clients, leveraging his extensive industry knowledge to provide insights that support strategic decision-making. Jose's former roles at Agennix as Associate Director, Research & Business Development; Senior Manager; and Manager in the same department further demonstrate his progressive career in research and business development, while his tenure as an Associate at Murphree Venture Partners highlights his involvement in providing strategic investment insights.

Additionally, Jose is also known for his altruistic contributions, having served as a Founder, Volunteer, and Consultant at CaringWings, where he utilized his expertise to guide initiatives aimed at improving healthcare outcomes.

In summary, Jose Engelmayer is a forward-thinking biopharmaceutical professional with a wealth of knowledge, extensive experience in drug development and commercialization, and a proven track record of achieving significant results. His willingness to extend his expertise beyond corporate environments reflects his dedication to advancing healthcare initiatives and supporting community wellbeing. His career continues to inspire others in the industry as he expertly navigates the complexities of biopharmaceutical strategies while staying focused on meaningful outcomes.

Achievements

Identified best early-stage, late-stage, and commercial drugs, unmet needs, current and future trends, competitive landscapes and tactics, threats, opportunities, and strategies for growth.

tags

Jose Engelmayer
Add to my network

Location

Houston, Texas